Icosapent ethyl modulates circulating vascular regenerative cell content: The IPE-PREVENTION CardioLink-14 trial.

Randomized controlled trial · Med · 2024. Source record refreshed; an explanation has not been reviewed.

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Bakbak E, Krishnaraj A, Bhatt DL et al.
Med · 2024

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.